Jufang Shi

Chinese Academy of Medical Sciences & Peking Union Medical College — China

Medicine · Health Sciences

37h-index4.6kcitations169works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Global Cancer Incidence and Screening(48), Cervical Cancer and HPV Research(34), Colorectal Cancer Screening and Detection(31), Economic and Financial Impacts of Cancer(25), Health Systems, Economic Evaluations, Quality of Life(22)

Publications168 total

Target trial emulation in oncology: current use and future directions
Military Medical Research·2026Open Access
Additional file 1 of Target trial emulation in oncology: current use and future directions
Figshare·2026Open Access
Target trial emulation in oncology: current use and future directions
Figshare·2026Open Access
Target trial emulation in oncology: current use and future directions
Figshare·2026Open Access
Additional file 1 of Target trial emulation in oncology: current use and future directions
Figshare·2026Open Access
Elucidating a Myofibroblast-dominated Fibrotic Niche in Crohn’s Disease-associated Fibrostenosis Through High-resolution Spatial Transcriptomics
Cellular and Molecular Gastroenterology and Hepatology·2025Open Access
Indirect economic burden of cancer in populations in China, 2021: A measurement based on a human capital approach
Journal of Cancer Policy·2025
Construction and verification of nomogram prediction model for non-suicidal self-injury in adolescents with depression
BMC Psychology·2025Open Access
OA05.01 ASTRUM-002: First-Line Serplulimab Plus Chemotherapy With or Without HLX04 in Advanced Nonsquamous Non-Small Cell Lung Cancer
Journal of Thoracic Oncology·2025
LBA71 Final analysis of first-line serplulimab plus chemotherapy with or without HLX04 in advanced nonsquamous non-small cell lung cancer: The ASTRUM-002 phase III study
Annals of Oncology·2025· 1 citedOpen Access
Diagnostic efficacy of fecal-based miR-92a for advanced colorectal neoplasia: a prospective multicenter screening trial
Military Medical Research·2025Open Access
145P: Efficacy and safety of aumolertinib as adjuvant therapy in resectable stage I A NSCLC with high-risk factors and EGFRsensitizing mutations (APPOINT)
Journal of Thoracic Oncology·2025· 1 citedOpen Access
Construction and verification of nomogram prediction model for non-suicidal self-injury in adolescents with depression
2024Open Access
[Disease burden and economic burden of breast cancer in females in China: a synthesis analysis].
PubMed·2024· 2 cited
Global incidence trends of early-onset colorectal cancer and related exposures in early-life: an ecological analysis based on the GBD 2019
Frontiers in Public Health·2024· 15 citedOpen Access
Access to colorectal cancer screening in populations in China, 2020: A coverage‐focused synthesis analysis
International Journal of Cancer·2024· 13 cited
Combining fecal immunochemical testing and questionnaire-based risk assessment in selecting participants for colonoscopy screening in the Chinese National Colorectal Cancer Screening Programs: A population-based cohort study
PLoS Medicine·2024· 8 citedOpen Access
[Cost-effectiveness of pharmaceutical smoking cessation intervention in China primary cancer prevention].
PubMed·2024
Risk-Adapted Starting Age of Personalized Lung Cancer Screening
CHEST Journal·2024· 8 cited
Estimating the economic burden of colorectal cancer in China, 2019–2030: A population‐level prevalence‐based analysis
Cancer Medicine·2023· 11 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Min Dai(25), Jiansong Ren(24), You‐Lin Qiao(15), Ni Li(15), Huiyao Huang(14), Xianzhen Liao(14), Jie He(14), Wanqing Chen(12), Lanwei Guo(12), Guoxiang Liu(11), Ayan Mao(11), Lingbin Du(9), Kai Zhang(9), Le Wang(8), Hongda Chen(8), Bingbing Song(8), Peian Lou(8), Karen Canfell(7), Yuqin Liu(7), Xiaojie Sun(7)